AU2002248338A1 - Identification of an advanced sleep phase syndrome gene in humans - Google Patents

Identification of an advanced sleep phase syndrome gene in humans

Info

Publication number
AU2002248338A1
AU2002248338A1 AU2002248338A AU2002248338A AU2002248338A1 AU 2002248338 A1 AU2002248338 A1 AU 2002248338A1 AU 2002248338 A AU2002248338 A AU 2002248338A AU 2002248338 A AU2002248338 A AU 2002248338A AU 2002248338 A1 AU2002248338 A1 AU 2002248338A1
Authority
AU
Australia
Prior art keywords
humans
identification
sleep phase
phase syndrome
advanced sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002248338A
Inventor
Ying-Hui Fu
Christopher Jones
Louis Ptacek
David Virshup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation UURF
Original Assignee
University of Utah Research Foundation UURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation UURF filed Critical University of Utah Research Foundation UURF
Publication of AU2002248338A1 publication Critical patent/AU2002248338A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002248338A 2001-01-11 2002-01-11 Identification of an advanced sleep phase syndrome gene in humans Abandoned AU2002248338A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26105401P 2001-01-11 2001-01-11
US60/261,054 2001-01-11
PCT/US2002/000741 WO2002055667A2 (en) 2001-01-11 2002-01-11 Identification of an advanced sleep phase syndrome gene in humans

Publications (1)

Publication Number Publication Date
AU2002248338A1 true AU2002248338A1 (en) 2002-07-24

Family

ID=22991764

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002248338A Abandoned AU2002248338A1 (en) 2001-01-11 2002-01-11 Identification of an advanced sleep phase syndrome gene in humans

Country Status (3)

Country Link
EP (1) EP1358315A4 (en)
AU (1) AU2002248338A1 (en)
WO (1) WO2002055667A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004038043A2 (en) * 2002-10-25 2004-05-06 University Of Surrey POLYMORPHISM IN THE Per3 GENE AS A INDICATOR IN THE DIAGNOSIS AND TREATMENT OF CIRCADIAN RHYTHM SLEEP DISORDERS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012952A1 (en) * 1997-09-09 1999-03-18 Research Development Foundation Mammalian circadian rhythm-like gene
WO2000075669A1 (en) * 1999-06-08 2000-12-14 Aventis Pharmaceuticals Inc. Screening methods for altering circadian rhythm proteins

Also Published As

Publication number Publication date
EP1358315A2 (en) 2003-11-05
WO2002055667A3 (en) 2003-04-17
WO2002055667A2 (en) 2002-07-18
EP1358315A4 (en) 2005-11-16

Similar Documents

Publication Publication Date Title
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002234755A1 (en) Interferon-alpha induced gene
AU2001251063A1 (en) 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
AU2002323299A1 (en) Systems and methods for manufacturing
AU2003247659A1 (en) Vapor-liquid contact tray and method employing same
AU2002336326A1 (en) Catalyst element and method for manufacture thereof
AU2003243594A1 (en) Novel boronic chalcone derivatives and uses thereof
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AUPS110302A0 (en) Novel chalcone derivatives and uses thereof
AU2002226656A1 (en) Flat coil
AU2002248338A1 (en) Identification of an advanced sleep phase syndrome gene in humans
AU2002257430A1 (en) Androgen-mediated neuroprotection and uses thereof
AU2002302551A1 (en) Flavone synthase i enzymes and the use thereof
AU2002365189A1 (en) P85-alpha nucleic acids, polypeptides and related methods
AU2002355155A1 (en) Methods for gene disruption and uses thereof
AU2002344181A1 (en) Combination of lipoic acids, carnitines, and creatines in food and pharmaceuticals
AU2003225036A1 (en) Cancer-associated nucleic acids and polypeptides
GB2383044B (en) Alstroem syndrome gene
AU2002347237A1 (en) Comparison of replicated data
AU2003265635A1 (en) Nphp nucleic acids and proteins
AU2003292721A1 (en) Novel protein and its gene
AU2002310591A1 (en) Interferon-alpha induced gene
AU2003220067A1 (en) Jade nucleic acids, proteins and uses thereof
AU2002314927A1 (en) Nucleic acid regulatory sequences and uses therefor
AU2003293150A1 (en) Casein kinase i epsilon and casein kinase i delta and sleep in humans

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase